Cel Sci Corporation (CVM)

[Biobonic]

For over a decade Geert has had to deal with these short sellers.

He knows them, he has had to take their money and see his companies' share price tumble as they laugh all the way to Warrant street.


Came across something he wrote in 2008, about manipulative shorting...

Aug 25, 2008 Updated Aug 22, 2008, 8:00am EDT
Cel-Sci Corp. Chief Executive Officer Geert Kersten was so frustrated by the swings in his company’s stock price Aug. 19 that he asked shareholders to write Capitol Hill to demand an investigation — a prospect finance experts doubt will ever happen.

Kersten wrote shareholders Aug. 20, a day after the Vienna company announced a licensing deal with Teva, an Israeli pharmaceutical company that will run a last trial for Cel-Sci’s best drug prospect. The drug, Multikine, uses the body’s immune system to attack cancerous tumors.

The company’s stock, traded on the American Stock Exchange, shot up to its year high of 78 cents and then settled at 60. As the closing bell neared, 280,000 shares were sold in the last minute, driving the price lower to 56.

In his letter to the company’s 15,000 shareholders, Kersten complained that the stock was being manipulated by short sellers, saying the shareholders “should be aware of the game that is being played with their company’s shares and not be intimidated.”

It's a long simmering animosity. From Warrant Series A to Double VV
Over 40 financings...
It became so regular, they had the shares shorted 'before' they got the deal done. It came back to burn them in 2018.